Avanos Medical AVNS Institutional Ownership

Ownership Summary

Avanos Medical, Inc. (NYSE:AVNS) has 251 institutional investors with active 13F positions as of March 2026.

• Their combined ownership stood at 8992.4% of outstanding shares in March 2026, down from 12522.7% in December 2025.
• They decreased total shares held in Avanos Medical by -21.76% from last quarter, and the number of investors in AVNS decreased 9.39% annually.
• Of these 251 holders, 100 added to their stakes in Avanos Medical, 72 trimmed positions, and 79 made no changes.
• In total, institutional investors held 44.96Mn shares in Avanos Medical as of March 2026, down by 12.5Mn shares quarter on quarter, and down 321.55K shares year over year.
• BlackRock, Inc. is the top holder of Avanos Medical as of March 31, 2026, with 6.84Mn shares representing 1368.75% of outstanding stock.
• The largest buyers of Avanos Medical for the quarter ending March 2026 were VANGUARD CAPITAL MANAGEMENT LLC (1.97Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.24Mn), BOONE CAPITAL MANAGEMENT LLC (1.18Mn), THRIVENT FINANCIAL FOR LUTHERANS (975.74K), ROYCE & ASSOCIATES LP (453.0K).
• The largest sellers of Avanos Medical for the quarter ending March 2026 were NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (14.9Mn), ARMISTICE CAPITAL, LLC (1.2Mn), T. Rowe Price Investment Management, Inc. (886.73K), MILLENNIUM MANAGEMENT LLC (718.07K), Qube Research & Technologies Ltd (573.32K).
• Per Business Quant, the top 10 investors in AVNS for the quarter ending March 2026 include BlackRock, Inc. (6.84Mn), T. Rowe Price Investment Management, Inc. (5.33Mn), BROWN ADVISORY INC (2.23Mn), DIMENSIONAL FUND ADVISORS LP (2.05Mn), ARMISTICE CAPITAL, LLC (2.0Mn), State Street Corp (1.97Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.97Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.24Mn), ACADIAN ASSET MANAGEMENT LLC (1.21Mn), THRIVENT FINANCIAL FOR LUTHERANS (1.19Mn).